Real-World Data on the Prevalence of Treatment-Related Adverse Events and Reasons for Immunosuppressive Agent Discontinuation in Patients With Myasthenia Gravis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis
Neuromuscul. Disord. 2024 May 01;38(1)51-57, KC Dodd, R Ahmed, P Ambrose, JK Holt, S Jacob, MI Leite, JA Miller, PP San, J Spillane, S Viegas, J SussmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.